Financials
Financial year 2025
Revenue
€ 201.4 million
▲ 12% vs 2024
Profit
Healthy€ 4.2 million
▼ 62% vs 2024
Debts
Low€ 30 million
▲ 14% vs 2024
TAKEDA BELGIUM from Zaventem, company number BE0403054202, closed financial year 2025 with a result of € 4.2 million after tax. For that financial year TAKEDA BELGIUM recorded revenue of € 201.4 million and equity of € 52.6 million. Compared with financial year 2024, the result moved from € 10.9 million to € 4.2 million. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 9, 2025.
What happened at TAKEDA BELGIUM?
What happened at TAKEDA BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Aline Vandecappelle stepped down as director. NBB
- Bruno Rabillier stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 4.2 million (▼ 62% vs 2024). Source: NBB ↗
- Bruno Rabillier became a director. NBB
- Michael Nesrallah stepped down as director. NBB
- Aline Vandecappelle became a director. NBB
- Michael Nesrallah became a director. NBB
- Paul De Proft became a director. NBB
In short
From € 4.8 million profit in 2022 to € 4.2 million profit in 2025.
Paid € 10.1 million in corporate taxes since 2022.
Best year ever: 2024, with € 10.9 million profit.
Pays suppliers within 20 days on average.
A new publication or filing at TAKEDA BELGIUM? We notify you, reason included.
Follow TAKEDA BELGIUMNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind TAKEDA BELGIUM is Paul De Proft. The shares are held by Takeda Pharmaceutical International AG (100%).
Directors
According to the 2025 annual accounts
Paul De Proft
Director
since 2020
Aline Vandecappelle
Director
since 2023 · until 2029
Bruno Rabillier
Managing director
since 2024 · until 2029
Michael Nesrallah
Director
since 2022 · until 2024
Shareholders
Takeda Pharmaceutical International AG
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Da Vincilaan 7
1930 Zaventem
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 7 companies are registered at this address.
IQVIA Solutions Belgium
€ 33.1 million revenue · 2025
IQVIA RDS & INTEGRATED SERVICES BELGIUM
€ 45.6 million revenue · 2025
IM ASSOCIATES
€ 3.1 million gross margin · 2025
Orifarm Healthcare
€ 31.3 million revenue · 2025
IQVIA Cancer Research
€ 50,247 gross margin · 2025
+2 more
Details
- Company number
- 0403.054.202
- VAT number
- BE 0403.054.202
- Registered office
- Da Vincilaan 7, 1930 Zaventem
- Names & denominations
- TAKEDA BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 11 June 1945
- Peppol
- Active · Active since 26 Feb 2026
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsvoering en beheer
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering